-
1
1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH
منشور في 2010"…The IPSS still showed a decrease of 4.3 points at 2 years post-treatment. However, no clear dose response was observed and Qmax did not increase in this study. …"
احصل على النص الكامل
احصل على النص الكامل
احصل على النص الكامل
احصل على النص الكامل
article